Changes in T-cell subsets and clonal repertoire during chemoimmunotherapy with pembrolizumab and paclitaxel or capecitabine for metastatic triple-negative breast cancer.
Chun B, Pucilowska J, Chang S, Kim I, Nikitin B, Koguchi Y, Redmond WL, Bernard B, Rajamanickam V, Polaske N, Fields PA, Conrad V, Schmidt M, Urba WJ, Conlin AK, McArthur HL, Page DB.
Chun B, et al. Among authors: polaske n.
J Immunother Cancer. 2022 Jan;10(1):e004033. doi: 10.1136/jitc-2021-004033.
J Immunother Cancer. 2022.
PMID: 35086949
Free PMC article.
Clinical Trial.